Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Home eye tests could change glaucoma care

NCT ID NCT05325996

Diagnosis Sponsor: Wills Eye Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 21, 2026 · Updated 2 times

Summary

This study looked at whether people with glaucoma can use portable devices at home to check their eye pressure and vision. Over two years, 53 patients measured their eye pressure three times a day for a week every three months and tested their vision weekly. The goal was to see if home monitoring is practical and accurate compared to standard clinic tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that home monitoring is a reliable way to track glaucoma, reducing the need for frequent clinic visits.
What could go wrong
This is a small, completed feasibility study with only 53 participants. Home devices may not be as accurate as clinic equipment, and results may not apply to all glaucoma patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

53 people

The number who actually took part.

Started

Apr 2022

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 20-80 years 2. Mild and Moderate Open Angle Glaucoma (OAG) 3. Refraction under 12.00 diopter of spherical refractive error and astigmatism of less than 2.5 diopter. Exclusion Criteria: 1. Spherical refraction outside \> ± 12.00 D and cylinder correction \> +2.5 D. 2. Visual acuity worse than 20/50 either eye 3. Cataract surgery with or without Minimally Invasive Glaucoma Surgery (MIGS) less than 90 days prior to enrollment 4. Filtering surgeries less than 6 months prior to enrollment 5. Intraocular surgery other than: 1. Non-complicated MIGS more than 90 days prior to enrollment; 2. Cataract or refractive surgery performed more than 90 days before enrollment and without posterior capsule opacification 3. Other glaucoma surgery more than 6 months prior to enrollment. 6. History of systemic or ocular condition (other than glaucoma or mild to moderate cataract) known to affect visual function. 7. History of medication known to affect visual function or influence patient reaction time 8. Inability to use device after remote training session 9. Subjects unwilling and/or unable to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Glaucoma, open-angle are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Glaucoma, open-angle

Contacts and locations

Locations

  • Wills Eye Hospital

    Philadelphia, Pennsylvania, 19107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.